I asked Ric Schumacher for an update. Let’s just say it’s no secret that a Bioavailability study was done. It’s no secret that Ric Schumacher wanted the third-party results out fast and that’s why he said he was checking each day each week when he spoke publicly months ago. I told you guys a long time ago. We should be having one press release a week and we fell short of that…now with the 2022 conference call due out and other press releases around the corner. He said he will update it the next time the company puts something in writing. We also know already that we’re looking forward to some kind of great results because that was mentioned publicly, so what kind of delay could we have either a medical journal or having to re-verify results that are out of whack to the whole industry. Again, I really don’t know the exact results but I’m gonna make a wild guess that it won’t be good for the competitors and PBIO is a great buyout candidate for 1000 different reasons. I know I’m just a jerk off IR Guy, but that’s my educated opinion.